Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mamoru Hashimoto

Showing results (171-180 of 195) with videos related to

Pageof 20
Sort By:
Cancer Medicine|May 14, 2025
EIF2S1 in Urinary Extracellular Vesicles as a Novel Diagnostic Marker for Bladder CancerEisuke Tomiyama, Kazutoshi Fujita, Kyosuke Matsuzaki, et al.
Scientific Reports|January 13, 2026
Comparative efficacy of immune checkpoint inhibitor combination therapies by metastatic site in metastatic renal cell carcinomaShingo Toyoda, Lan Inoki, Mamoru Hashimoto, et al.
Scientific Reports|July 2, 2025
Comparison of genetic mutations in bladder cancers that arose following radiotherapy for prostate cancer with those in primary bladder cancersShogo Adomi, Kazuko Sakai, Yurie Kura, et al.
International Psychogeriatrics|January 31, 2025
Validation of the Japanese version of the Social Functioning in Dementia scale and COVID-19 pandemic's impact on social function in mild cognitive impairment and mild dementiaSumiyo Umeda, Hideki Kanemoto, Maki Suzuki, et al.
Journal of the American Geriatrics Society|May 17, 2011
Open label trial to evaluate the efficacy and safety of Yokukansan, a traditional Asian medicine, in dementia with Lewy bodiesKoh Iwasaki, Kenji Kosaka, Hideo Mori, et al.
Urologic Oncology|December 28, 2025
Comparison of prostate-specific antigen kinetics between androgen receptor signaling inhibitor doublet therapy and androgen receptor signaling inhibitor with docetaxel triplet therapy in patients with metastatic castration-sensitive prostate cancerTsuyoshi Morita, Yutaka Yamamoto, Saizo Fujimoto, et al.
Psychogeriatrics : the Official Journal of the Japanese Psychogeriatric Society|December 28, 2023
Utility of the Japanese version of the Clinical Dementia Rating® plus National Alzheimer's Coordinating Centre Behaviour and Language Domains for sporadic cases of frontotemporal dementia in JapanDaiki Taomoto, Shunsuke Sato, Hideki Kanemoto, et al.
International Psychogeriatrics|March 11, 2024
Validation of the Japanese version of the Social Functioning in Dementia scale and COVID-19 pandemic's impact on social function in mild cognitive impairment and mild dementiaSumiyo Umeda, Hideki Kanemoto, Maki Suzuki, et al.
Translational Andrology and Urology|August 25, 2021
Higher neutrophil-to-lymphocyte ratio after the first cycle of the first-line chemotherapy is associated with poor cancer specific survival of upper urinary tract carcinoma patientsMamoru Hashimoto, Kazutoshi Fujita, Takahito Nakayama, et al.
Journal of Cancer Research and Clinical Oncology|April 9, 2024
Comparison of the efficacy of enfortumab vedotin between patients with metastatic urothelial carcinoma who were treated with avelumab or pembrolizumab: real-world data from a multi-institutional study in JapanYosuke Hirasawa, Takahiro Adachi, Takeshi Hashimoto, et al.
Pageof 20

Showing results (171-180 of 195) with videos related to

Sort By:
Pageof 20
Cancer Medicine|May 14, 2025
EIF2S1 in Urinary Extracellular Vesicles as a Novel Diagnostic Marker for Bladder CancerEisuke Tomiyama, Kazutoshi Fujita, Kyosuke Matsuzaki, et al.
Scientific Reports|January 13, 2026
Comparative efficacy of immune checkpoint inhibitor combination therapies by metastatic site in metastatic renal cell carcinomaShingo Toyoda, Lan Inoki, Mamoru Hashimoto, et al.
Scientific Reports|July 2, 2025
Comparison of genetic mutations in bladder cancers that arose following radiotherapy for prostate cancer with those in primary bladder cancersShogo Adomi, Kazuko Sakai, Yurie Kura, et al.
International Psychogeriatrics|January 31, 2025
Validation of the Japanese version of the Social Functioning in Dementia scale and COVID-19 pandemic's impact on social function in mild cognitive impairment and mild dementiaSumiyo Umeda, Hideki Kanemoto, Maki Suzuki, et al.
Journal of the American Geriatrics Society|May 17, 2011
Open label trial to evaluate the efficacy and safety of Yokukansan, a traditional Asian medicine, in dementia with Lewy bodiesKoh Iwasaki, Kenji Kosaka, Hideo Mori, et al.
Urologic Oncology|December 28, 2025
Comparison of prostate-specific antigen kinetics between androgen receptor signaling inhibitor doublet therapy and androgen receptor signaling inhibitor with docetaxel triplet therapy in patients with metastatic castration-sensitive prostate cancerTsuyoshi Morita, Yutaka Yamamoto, Saizo Fujimoto, et al.
Psychogeriatrics : the Official Journal of the Japanese Psychogeriatric Society|December 28, 2023
Utility of the Japanese version of the Clinical Dementia Rating® plus National Alzheimer's Coordinating Centre Behaviour and Language Domains for sporadic cases of frontotemporal dementia in JapanDaiki Taomoto, Shunsuke Sato, Hideki Kanemoto, et al.
International Psychogeriatrics|March 11, 2024
Validation of the Japanese version of the Social Functioning in Dementia scale and COVID-19 pandemic's impact on social function in mild cognitive impairment and mild dementiaSumiyo Umeda, Hideki Kanemoto, Maki Suzuki, et al.
Translational Andrology and Urology|August 25, 2021
Higher neutrophil-to-lymphocyte ratio after the first cycle of the first-line chemotherapy is associated with poor cancer specific survival of upper urinary tract carcinoma patientsMamoru Hashimoto, Kazutoshi Fujita, Takahito Nakayama, et al.
Journal of Cancer Research and Clinical Oncology|April 9, 2024
Comparison of the efficacy of enfortumab vedotin between patients with metastatic urothelial carcinoma who were treated with avelumab or pembrolizumab: real-world data from a multi-institutional study in JapanYosuke Hirasawa, Takahiro Adachi, Takeshi Hashimoto, et al.
Pageof 20